NASDAQ: HLTHCue Health Inc Stock
$0.46+0.02 (+4.55%)
Updated Sep 22, 2023
HLTH Price
$0.46
Fair Value Price
N/A
Market Cap
$70.46M
52 Week Low
$0.31
52 Week High
$4.38
P/E
-0.25x
P/B
0.17x
P/S
0.22x
PEG
N/A
Dividend Yield
N/A
Revenue
$251.03M
Earnings
-$275.87M
Gross Margin
16.1%
Operating Margin
-112%
Profit Margin
-109.9%
Debt to Equity
0.24
Operating Cash Flow
-$188M
Beta
1.49
Next Earnings
Nov 7, 2023
Ex-Dividend
N/A
Next Dividend
N/A
HLTH Overview
Cue Health Inc., a healthtech company, offers a platform for diagnostic tests. Customers include enterprises, healthcare providers and payors, and public health agencies. Offerings include the Cue Integrated Care platform, Cue Data and Innovation Layer, Cue Virtual Care Delivery Apps, and Cue Ecosystem Integrations and Apps. Cue Health was incorporated in 2010 and is headquartered in San Diego, CA.
Zen Score
–
Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how HLTH scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
HLTH is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
HLTH is good value based on its book value relative to its share price (0.17x), compared to the US Health Information Services industry average (3.08x)
P/B vs Industry Valuation
HLTH is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more HLTH due diligence checks available for Premium users.
Be the first to know about important HLTH news, forecast changes, insider trades & much more!
HLTH News
Valuation
HLTH price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.25x
Industry
54.73x
Market
14.52x
HLTH price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.17x
Industry
3.08x
HLTH is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
HLTH's financial health
Profit margin
Revenue
$9.9M
Net Income
-$83.9M
Profit Margin
-847.5%
HLTH's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
HLTH's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$523.9M
Liabilities
$100.7M
Debt to equity
0.24
HLTH's short-term assets ($212.08M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
HLTH's short-term assets ($212.08M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
HLTH's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$42.7M
Investing
-$6.0M
Financing
-$996.0k
HLTH's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
HLTH vs Health Information Service Stocks
Cue Health Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.